Huahai Pharmaceutical announced on the evening of October 17. Recently, the company's brief application for a new drug for englizin metformin tablets declared to the US FDA has been temporarily approved. Empagliflozin metformin tablets are mainly used to treat type II diabetes.

Huahai Pharmaceutical announced on the evening of October 17. Recently, the company's brief application for a new drug for englizin metformin tablets declared to the US FDA has been temporarily approved. Empagliflozin metformin tablets are mainly used to treat type II diabetes.